Local tumor progression following lipiodol-based targeted chemoembolization of hepatocellular carcinoma: a retrospective comparison of miriplatin and epirubicin

PURPOSE: We aimed to compare the local control rates between miriplatin and epirubicin in lipiodol-based transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC). PATIENTS AND METHODS: Patients who underwent targeted TACE using miriplatin (47 patients, 66 lesions) or epirubicin (64...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Iwazawa, Jin, Ohue, Shoichi, Hashimoto, Naoko, Mitani, Takashi
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2012
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3346199/
https://ncbi.nlm.nih.gov/pubmed/22570565
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S30431
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky